More importantly, we found that SM-164 significantly enhanced APO2L/TRAIL-mediated cell death induction in 7 out of 12 of fresh isolated HCC cells from tumor samples, highlighting the clinical relevance of using Smac mimetics cooperated with APO2L/TRAIL in human HCC therapy. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.